Should You Buy Stryker Corp (SYK) Stock on Tuesday?

Stryker Corp (SYK) stock has gained 3.81% over the past week and gets a Bullish rating from InvestorsObserver Sentiment Indicator.

Stryker Corp has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on SYK!

See Full SYK Report

What is Stock Sentiment?

In investing, sentiment generally means whether or not a given security is in favor with investors. It is typically a pretty short-term metric that relies entirely on technical analysis. That means it doesn’t incorporate anything to do with the health or profitability of the underlying company. Sentiment is how investors, or the market, feels about a stock. There are lots of ways to measure sentiment. At the core, sentiment is pretty easy to understand. If a stock is going up, investors must be bullish, while if it is going down, sentiment is bearish. InvestorsObserver’s Sentiment Indicator looks at price trends over the past week and also considers changes in volume. Increasing volume can mean a trend is getting stronger, while decreasing volume can mean a trend is nearing a conclusion. For stocks that have options, our system also considers the balance between calls, which are often bets that the price will go up, and puts, which are frequently bets that the price will fall.

What's Happening With SYK Stock Today?

Stryker Corp (SYK) stock is trading at $285.49 as of 3:08 PM on Tuesday, Nov 14, an increase of $3.65, or 1.3% from the previous closing price of $281.84. The stock has traded between $283.33 and $288.25 so far today. Volume today is low. So far 713,790 shares have traded compared to average volume of 1,918,242 shares. To screen for more stocks like Stryker Corp click here.

More About Stryker Corp

Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and spinal devices. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Nearly one fourth of Stryker's total revenue currently comes from outside the United States. Click Here to get the full Stock Report for Stryker Corp stock.